Florida legislation · 2026 Regular Session
Florida S1158: Drug Prices and Coverage
Status: Failed, March 13, 2026
Requiring the Agency for Health Care Administration to contract with an entity to designate reference price source countries and analyze certain data; requiring the agency to publish annually prescription drug reference prices; prohibiting pharmacies from charging cash-paying customers more than the reference prices for prescribed drugs and biological products; requiring prescription drug manufacturer permitholders to annually report to the agency international drug price data beginning on a specified date; requiring certain health insurers to limit covered prescription drug reimbursement to reference prices, etc.
What the bill says
An act relating to drug prices and coverage; creating s. 381.02036, F.S.; requiring the Agency for Health Care Administration to contract with an entity to designate reference price source countries and analyze certain data; defining the term "real gross domestic product per capita"; providing duties for the contracted entity; requiring the agency to publish annually prescription drug reference prices; amending s. 465.0244, F.S.; prohibiting pharmacies from charging cash-paying customers more than the reference prices for prescribed drugs and biological products…
From the introduced text, January 6, 2026:
A bill to be entitled An act relating to drug prices and coverage; creating s. 381.02036, F.S.; requiring the Agency for Health Care Administration to contract with an entity to designate reference price source countries and analyze certain data; defining the term "real gross domestic product per capita"; providing duties for the contracted entity; requiring the agency to publish annually prescription drug reference prices; amending s. 465.0244, F.S.; prohibiting pharmacies from charging cash-paying customers more than the reference prices for prescribed drugs and biological products; providing applicability; creating s. 499.044, F.S.; providing legislative intent; defining the terms "prescription drug" and "drug"; requiring prescription drug manufacturer permitholders to annually report to the agency international drug price data beginning on a specified date; specifying reporting requirements and penalties; amending s. 626.8825, F.S.; defining terms; requiring that contracts between pharmacy benefit managers and pharmacy benefits plans and programs prohibit pharmacy benefit managers from offering and implementing certain formularies; requiring that contracts between pharmacy benefit managers and participating pharmacies allow a specified option in the administrative appeal procedure; amending s. 626.8827, F.S.; prohibiting pharmacy benefit managers from engaging in certain practices relating to pharmacies and pharmacists; creating s. 627.4231, F.S.; defining terms; requiring certain health insurers to limit covered prescription drug reimbursement to reference prices; requiring that savings from such reimbursement limits be used …